Arcadia Biosciences, Inc.
RKDA
$3.40
-$0.0813-2.34%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.61M | 1.06M | -2.42M | -2.85M | -2.57M |
| Total Depreciation and Amortization | 157.00K | 209.00K | 228.00K | 222.00K | 267.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -58.00K | -3.59M | -417.00K | -266.00K | -204.00K |
| Change in Net Operating Assets | -239.00K | -138.00K | -598.00K | -1.21M | -381.00K |
| Cash from Operations | -1.75M | -2.46M | -3.21M | -4.11M | -2.89M |
| Capital Expenditure | 0.00 | -3.00K | -13.00K | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | 180.00K | 145.00K | 17.00K | 73.00K | 5.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 4.50M | -- | -21.00K | 0.00 |
| Cash from Investing | 180.00K | 4.64M | 4.00K | 52.00K | 5.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.00K | 0.00 | 5.00K | 0.00 | 7.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 4.00K | 0.00 | 5.00K | 0.00 | 7.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.57M | 2.19M | -3.20M | -4.05M | -2.87M |
